A leading cardiology journal has named an academic paper written by Oxford BRC-supported researchers as its best research paper of 2020.
The paper – which found that two common heart medication do not increase the risk of COVID-19 hospitalisation – was named by the BMJ Heart journal as the Heart Best Research Paper Award 2021 in recognition of its “high quality and clinical impact”.
The paper – Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people – was led byProfessorJulia Hippisley-Cox (pictured) and included investigators from a number of Oxford BRC themes.
Every year, the Heart editorial team selects the most meritorious research papers it has published. Primary considerations are the relevance of the clinical question addressed by the research, the quality of the research study design and data presentation, and the interest generated by the paper among other researchers, clinical cardiologists and the general public.
The 2021 award is for the best research paper published in the journal in 2020.
Heart is an international peer reviewed journal that is co-owned by the British Cardiovascular Society and BMJ.